<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458689</url>
  </required_header>
  <id_info>
    <org_study_id>1813</org_study_id>
    <nct_id>NCT03458689</nct_id>
  </id_info>
  <brief_title>Quadratus Lumborum Block Versus Transversus Abdominis Plane Block in Patients Undergoing Left Hemicolectomy</brief_title>
  <official_title>Quadratus Lumborum Block Versus Transversus Abdominis Plane Block in Patients Undergoing Left Hemicolectomy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ostfold Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ostfold Hospital Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The enhanced recovery after surgery and laparoscopic approach have been proven beneficial in&#xD;
      surgery of the colon. However, patients have still pain, nausea and vomiting postoperatively.&#xD;
      Postoperative pain is an expected but undesirable effect after an operation. This study will&#xD;
      compare Transabdominis Plane (TAP) Block and Quadratus Lumborum (QL) Block with the common&#xD;
      postoperative treatment with enteral and parenteral analgesics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TAP is a recommended multimodal method of reducing postoperative pain in laparoscopic and&#xD;
      open surgery. TAP block seems to be feasible and effective in postoperative pain control&#xD;
      without increasing morbidity in colon resections. QL block is also performed as one of the&#xD;
      perioperative pain management procedures in abdominal surgery. It is regarded as an effective&#xD;
      analgesic tool. The dermatomal effects of QL block reach higher than the TAP block, and might&#xD;
      explain the better effect of the QL block than TAP blocks on postoperative pain after&#xD;
      caesarean delivery. For this study the investigators standardize the type of surgery to be&#xD;
      left hemicolectomy. This is the most common procedure on colon.&#xD;
&#xD;
      Power and Sample Size Calculator:&#xD;
&#xD;
      The number of patients required for the study was calculated on the basis of opioid&#xD;
      consumption. We were interested in a reduction by 20% in the group given QLB. Assuming&#xD;
      α=0,05, we calculated that we need 69 patients (23 in each group) to achieve a power of 80%&#xD;
      (β=0.2).&#xD;
&#xD;
      75 adult patients scheduled for left hemicolectomy have to be included.&#xD;
&#xD;
      Subcutaneous wound infiltration at the end of surgery in all patients with ropivacaine 2&#xD;
      mg/ml, 20 ml. Maximum allowed dosis of Ropivacain is 3 mg/kg bodyweight (BW), dosis reduction&#xD;
      if BW&lt;70 kg Premedication: Paracetamol 2 g and Diklofenak 100 mg orally. General anaesthesia:&#xD;
      TCI: Propofol and Remifentanil Ondansetron 4 mg, dexamethasone 8 mg and Oxycodone 5 mg&#xD;
      intravenously at the end of surgery.&#xD;
&#xD;
      Postoperatively:&#xD;
&#xD;
      Oral paracetamol and codeine-fixed combination up to 1000 mg and 60 mg, respectively, every 6&#xD;
      h In case of insufficient analgesia, as judged by the patient, oxycodon 2 - 5 mg IV.&#xD;
&#xD;
      When nausea and vomiting occure postoperatively, ondansetron 4 mg IV administers as the drug&#xD;
      of first choice followed by droperidol 0,625 mg IV if the nausea/vomiting persists.&#xD;
&#xD;
      Collected data:&#xD;
&#xD;
      Postoperative pain at rest and during activity evaluated by a 4-points verbal pain score&#xD;
      (VPS; with no pain=0, slight pain = 1, Moderate pain = 2, and severe pain = 3) on admission&#xD;
      to recovery, and every hour until discharge.&#xD;
&#xD;
      Rescue analgesic consumption during 0 to 4, 4 to 24 and 24 to 48 h. Sedation, nausea and&#xD;
      vomiting record by the same 0 - 3 scale (none, slight, moderate, strong) during recovery Time&#xD;
      of postoperative mobilization with corresponding pain score. Time of discharge-to-home or&#xD;
      ward readiness according to standard criteria, including stable vital signs, no bleeding from&#xD;
      the surgical site, ability to void, absence of excessive nausea and pain, and ability to&#xD;
      dress and walk without support.&#xD;
&#xD;
      Side effects including nausea and/or vomiting (0 to 4, 4 to 24, and 24 to 48 h), antiemetics&#xD;
      administered (0 to 24 and 24 to 48 H), grade of sedation (0 to 10 scale, where 0 = awake, and&#xD;
      10 = aroused on stimulation), and other side effects and symptoms of LA toxicity.&#xD;
&#xD;
      Telephone interview at 24 h, 48 h and 7 days, with questions:&#xD;
&#xD;
      Pain during rest and activity using the VPS Total need of analgesics Sedation Nausea Level of&#xD;
      activity Overall satisfaction with the per- and postoperative period on a 0 - 3 scale: not&#xD;
      satisfied, slight, moderate or highly satisfied.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 28, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Information connecting the patients to the data are kept locked and will be destroyed after the end of the investigation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Use of analgesics - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>Amount of analgesics used postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at the incision site - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>VPS (Verbal Pain Score): No pain = 0, Slight pain = 1, Moderate pain= 2, Severe pain = 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep pain and pain on coughing - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>VPS (Verbal Pain Score): No pain = 0, Slight pain = 1, Moderate pain= 2, Severe pain = 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nonsteroidal anti-inflammatory drug consumption - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>Amount of different medicaments in mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>0 - 3 score where None = 0, Little nausea = 1, Can not eat = 2, Vomiting = 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antiemetic administered - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>Amount of different medicaments in mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation scores - &quot;change&quot; is being assessed</measure>
    <time_frame>1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)</time_frame>
    <description>Sleepy or active. Score: Awake = 0, Tired = 1, Falls asleep = 2, Asleep all the time = 3</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Colon Neoplasm</condition>
  <condition>Surgery</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Left hemicolectomy without nerve blocks</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Left hemicolectomy, laparoscopic technique Enteral and parenteral analgesics such as paracetamol and oksykodon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left hemicolectomy with TAP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Left hemicolectomy, laparoscopic technique TAP block bilateral with Naropin 3,75 mg/ml, 2 x 20 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left hemicolectomy with QL block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Left hemicolectomy, laparoscopic technique QL block bilateral with Naropin 3,75 mg/ml, 2 x 20 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left hemicolectomy, laparoscopic technique</intervention_name>
    <description>Left hemicolectomy, Laparoscopic technique</description>
    <arm_group_label>Left hemicolectomy with QL block</arm_group_label>
    <arm_group_label>Left hemicolectomy with TAP block</arm_group_label>
    <arm_group_label>Left hemicolectomy without nerve blocks</arm_group_label>
    <other_name>QL block bilateral with ropivacain 3,75 mg/ml (2 x 20 ml)</other_name>
    <other_name>TAP block with ropivacain 3,75 mg/ml (2 x 20 ml)</other_name>
    <other_name>Traditional analgesics such as paracetamol and oksycodon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-80 Years&#xD;
&#xD;
          -  BMI 20-35&#xD;
&#xD;
          -  ASA physical status I-II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to LA&#xD;
&#xD;
          -  Chronic pain requiring opioid analgesics&#xD;
&#xD;
          -  Patients with atrioventricular block II&#xD;
&#xD;
          -  Patients treated with class III antiarrhythmics&#xD;
&#xD;
          -  Patients with severe renal and/or hepatic disease&#xD;
&#xD;
          -  A coagulation disorder&#xD;
&#xD;
          -  An infection at the LA injection place&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Sverre Vamnes, MD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior Consultant</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Sverre Vamnes, MD, Ph.D.</last_name>
    <phone>0047 91305016</phone>
    <email>janvam@so-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Klaus Risnes, MD</last_name>
    <phone>0047 99329515</phone>
    <email>klaris@so-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ostfold Hospital Trust, Moss</name>
      <address>
        <city>Grålum</city>
        <state>Ostfold</state>
        <zip>1714</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Sverre Vamnes, MD, Ph.D.</last_name>
      <phone>+47 91608896</phone>
      <email>janvam@so-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Knut Inge Solbakk, md</last_name>
      <phone>+47 90933106</phone>
      <email>knisol@so-hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Børglum J, Gögenür I, Bendtsen TF. Abdominal wall blocks in adults. Curr Opin Anaesthesiol. 2016 Oct;29(5):638-43. doi: 10.1097/ACO.0000000000000378. Review.</citation>
    <PMID>27429253</PMID>
  </results_reference>
  <results_reference>
    <citation>Blanco R, Ansari T, Riad W, Shetty N. Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):757-762. Erratum in: Reg Anesth Pain Med. 2018;43:111.</citation>
    <PMID>27755488</PMID>
  </results_reference>
  <results_reference>
    <citation>El-Dawlatly AA, Turkistani A, Kettner SC, Machata AM, Delvi MB, Thallaj A, Kapral S, Marhofer P. Ultrasound-guided transversus abdominis plane block: description of a new technique and comparison with conventional systemic analgesia during laparoscopic cholecystectomy. Br J Anaesth. 2009 Jun;102(6):763-7. doi: 10.1093/bja/aep067. Epub 2009 Apr 17. Erratum in: Br J Anaesth. 2009 Oct;103(4):622.</citation>
    <PMID>19376789</PMID>
  </results_reference>
  <results_reference>
    <citation>Murouchi T, Iwasaki S, Yamakage M. Quadratus Lumborum Block: Analgesic Effects and Chronological Ropivacaine Concentrations After Laparoscopic Surgery. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):146-50. doi: 10.1097/AAP.0000000000000349.</citation>
    <PMID>26735154</PMID>
  </results_reference>
  <results_reference>
    <citation>Pirrera B, Alagna V, Lucchi A, Berti P, Gabbianelli C, Martorelli G, Mozzoni L, Ruggeri F, Ingardia A, Nardi G, Garulli G. Transversus abdominis plane (TAP) block versus thoracic epidural analgesia (TEA) in laparoscopic colon surgery in the ERAS program. Surg Endosc. 2018 Jan;32(1):376-382. doi: 10.1007/s00464-017-5686-7. Epub 2017 Jul 1.</citation>
    <PMID>28667547</PMID>
  </results_reference>
  <results_reference>
    <citation>Ueshima H, Otake H, Lin JA. Ultrasound-Guided Quadratus Lumborum Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:2752876. doi: 10.1155/2017/2752876. Epub 2017 Jan 3. Review.</citation>
    <PMID>28154824</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ostfold Hospital Trust</investigator_affiliation>
    <investigator_full_name>Jan Sverre Vamnes</investigator_full_name>
    <investigator_title>Senior conultant, Ph.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

